Wellfully Limited (WFL.AX)

0.0030 0.0000 (0.00%) As of 04:02PM AEDT. Market open.

Wellfully Limited

101 St Georges Terrace
Level 3
Perth, WA 6001
Australia
61 8 6558 0886
https://www.wellfully.net

Sector(s): Healthcare
Industry: Diagnostics & Research
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Paul Peros	MD & CEO	577.68k	N/A	N/A
Mr. Sergej Dolezil	Chief Financial Officer	N/A	N/A	N/A
Dr. Matthew McIldowie	Chief Scientific Officer	N/A	N/A	N/A
Mr. Blagojce Pavlovski	Company Secretary	N/A	N/A	N/A

Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.

Description

Wellfully Limited, together with its subsidiaries, focuses on the development and commercialization of Dermaportation and ETP transdermal drug delivery technologies. It operates in two segments, Dermaportation Drug Delivery Technology and Devices. The company is also involved in the industrialization and supply-chain support for its existing product ranges; and sale and marketing of its own brands REDUIT and SWISSWELL, as well as third-party collaborations. It serves the pharmaceutical, cosmetic and skincare, and consumer healthcare sectors. The company was formerly known as OBJ Limited and changed its name to Wellfully Limited in September 2020. Wellfully Limited was incorporated in 1992 and is based in Perth, Australia.

Corporate governance

Wellfully Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.